Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clough, K. B.
Right arrow Articles by Durand, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clough, K. B.
Right arrow Articles by Durand, J. C.

Annals of Surgical Oncology, Vol 3, Issue 2 212-218, Copyright © 1996 by Society of Surgical Oncology

ARTICLES

Immediate breast reconstruction by prosthesis: a safe technique for extensive intraductal and microinvasive carcinomas

K. B. Clough, D. Bourgeois, M. C. Falcou, C. Renolleau and J. C. Durand
Service de Chirurgie, Institut Curie, Paris, France.

BACKGROUND: Immediate breast reconstruction (IBR) by prosthesis is frequently proposed after mastectomy. However, due to the morbidity of this operation, especially the early implant removal rate, its indications remain controversial. METHODS: We have performed 141 IBR by prosthesis (saline or gel-filled implant, tissue expander) in a homogeneous population of patients with extensive intraductal or microinvasive carcinoma, diagnosed after an initial local excision. This prospective study was designed to assess the feasibility and morbidity of IBR for an "ideal" population, allowing wide cutaneous preservation, without preoperative or postoperative treatment. RESULTS: The early prosthesis removal rate (< 2 months) was 0.7%, with only 2.1% of early surgical revisions and 3% of lymphoceles. Cutaneous complications (5%) were significantly correlated with the type of incision. Cosmetic results at 1 year were good or very good in 66% of cases, similar to the percentage observed after delayed reconstruction by prosthesis. CONCLUSIONS: In this selected population, IBR by prosthesis did not induce any additional morbidity compared with mastectomy without reconstruction. IBR by prosthesis can be systematically proposed in cases of extensive intraductal or microinvasive carcinoma.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
P. Ananian, G. Houvenaeghel, C. Protiere, P. Rouanet, S. Arnaud, J.P. Moatti, A. Tallet, A.C. Braud, and C. Julian-Reynier
Determinants of Patients' Choice of Reconstruction with Mastectomy for Primary Breast Cancer
Ann. Surg. Oncol., August 1, 2004; 11(8): 762 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. N. van Geel, C. M. E. Contant, R. T. J. Wai, P. I. M. Schmitz, A. M. M. Eggermont, and M. M. E. Menke-Pluijmers
Mastectomy by Inverted Drip Incision and Immediate Reconstruction: Data From 510 Cases
Ann. Surg. Oncol., May 1, 2003; 10(4): 389 - 395.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Society of Surgical Oncology.